Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Elisabetta Pace (Palermo, Italy), Maria Ferraro, Mark Gjomarkaj, Liboria Siena, Serena Di Vincenzo, Elisabetta Pace. Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells. Eur Respir J 2015; 46: Suppl. 59, 3901

Member's Comments

No comment yet.

Related content which might interest you: Anti-inflammatory effect of beclomethasone dipropionate and formoterol on TNF-α-induced human endothelial cell activation Source: Annual Congress 2011 - Lung cell biology Year: 2011 Differential effects of budesonide and fluticasone propionate on expression of lactotransferrin in airway epithelium Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Differential effects of budesonide and fluticasone propionate on bronchial epithelial barrier function Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Comparative anti-oxidant effects of carbocysteine and fluticasone propionate in cigarette smoke stimulated airway epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012 Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008 Initial interaction of fluticasone propionate with ciliated respiratory epithelium Source: International Congress 2016 – Pulmonary drug delivery Year: 2016 Additive blockade of β2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate Source: Eur Respir J 2004; 23: 511-517 Year: 2004 Multiple synergistic effects of fluticasone propionate and salmeterol on T-cell activation in bronchial asthma Source: Eur Respir J 2004; 24: Suppl. 48, 250s Year: 2004 Anti-inflammatory effect and clinical efficacy of concomitant treatments to steroid inhaler in bronchial asthma: montelukast versus salmeterol Source: Eur Respir J 2006; 28: Suppl. 50, 315s Year: 2006 Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects Source: Annual Congress 2013 –The pulmonary epithelium: recent developments Year: 2013 Inhibitory effects of formoterol, budesonide and tiotropium bromide on human neutrophils in vitro Source: Eur Respir J 2003; 22: Suppl. 45, 286s Year: 2003 Timecourse of action of two inhaled corticosteroids, fluticasone propionate and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 308s Year: 2002 Anti-inflammatory effects of salmeterol/fluticasone propionate (SFC) on airway T-lymphocyte populations in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 203s Year: 2005 Effect of fluticasone and formoterol combination therapy on airway remodeling Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Additive blockade of β2-integrin adhesion of eosinophils by salmeterol and fluticasone propionate Source: Eur Respir J 2004; 24: 333 Year: 2004 Scientific rationale for inhaled combination therapy with long-acting β2-agonists and corticosteroids Source: Eur Respir J 2002; 19: 182-191 Year: 2002 Effects of ciclesonide and fluticasone on cortisol secretion in patients with persistent asthma Source: Eur Respir J 2009; 33: 1277-1286 Year: 2009 Interaction between aclidinium bromide and formoterol fumarate; effects on human bronchial smooth muscle Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Interaction between aclidinium bromide and formoterol fumarate in small human airways Source: International Congress 2014 – Novel approaches and evidence for drug development in respiratory diseases Year: 2014 Synergistic interaction between beclomethasone diproprionate and formoterol fumarate in an ex vivo model of bronchial asthma Source: International Congress 2018 – Basic pharmacology Year: 2018